Why neural stem cells may be vulnerable to Zika
30 March 2016 | By Victoria White
Neural stem cells that express AXL, only present during the 2nd trimester of pregnancy, may be linked to how Zika is able to produce cases of microcephaly...
List view / Grid view
News
‘Outlier’ enzymes identified as potential targets to treat diabetes
30 March 2016 | By Victoria White
Scientists have discovered two enzymes - AIG1 and ADTRP - that appear to play a role in metabolism and inflammation...
Amal Therapeutics completes EUR 2.75 million Series A financing round
30 March 2016 | By Victoria White
Amal Therapeutics will use the funds to progress the preclinical development of ATP124 and to further develop its KISIMA technology platform...
A new clue to fighting acute myeloid leukaemia
29 March 2016 | By Victoria White
The findings, made by scientists at the National University of Singapore, open a new door to treating the AML more effectively...
A vaccine that protects against multiple H1N1 influenza strains
29 March 2016 | By Victoria White
Using a technique called COBRA, researchers created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza strains...
Inovio updates clinical strategy for INO-3112 HPV immunotherapy
29 March 2016 | By Victoria White
Inovio has updated its clinical strategy to take its INO-3112 HPV immunotherapy into human studies in combination with selected molecules from MedImmune...
Researchers identify promising drug combination for tuberculosis
29 March 2016 | By Victoria White
Researchers used feedback system control to quickly narrow combinations of 14 different tuberculosis drugs with five different doses into several promising combination treatments...
Dr Yong-Jun Lui appointed Sanofi’s Head of Research
29 March 2016 | By Victoria White
Dr Yong-Jun Liu has been appointed as Sanofi’s new Head of Research, Global R&D, effective...
Apogenix’s APG101 demonstrates efficacy in preclinical MDS study
24 March 2016 | By Victoria White
Apogenix’s APG101 rescues the production of red blood cells (erythropoiesis) in bone marrow samples from patients with lower-risk myelodysplastic syndromes...
Iterum licenses global rights to novel anti-infective compound
24 March 2016 | By Victoria White
Iterum has also secured a $40 million Series A financing, which will be used for the licensing and product development activities...
miR-155 deletion prevents diet-induced obesity in mice
23 March 2016 | By Victoria White
In a study, despite eating a high-fat diet for 3 months, miR-155 knockout mice did not become obese and had enhanced metabolic rates...
Researchers find new genetic target for NSCLC
23 March 2016 | By Victoria White
Researchers have identified mutations in NSCLC that are key to tumour growth, offering a new way to differentiate patients with the disease...
Bristol-Myers Squibb to acquire Padlock Therapeutics
23 March 2016 | By Victoria White
Padlock Therapeutics is a private biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases...
Scientists unravel the secret of antibiotic resistance
22 March 2016 | By Victoria White
Scientists have provided the first direct evidence of how proteins of the ABC-F family 'protect' the bacterial ribosome from being blocked by antibiotics...
Pfizer joins the Human Vaccines Project
22 March 2016 | By Victoria White
The Human Vaccines Project is focused on cross-sector collaboration to identify human immune responses associated with optimal vaccine protection...